The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

AIM WINNERS & LOSERS: Midatech shares soar on Bioasis acquisition

Mon, 19th Dec 2022 11:16

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Midatech Pharma PLC, up 37% at 2.88 pence, 12-month range 2.1p-20p. The biotechnology company provides an update on its agreement to acquire Bioasis Technologies Inc for CAD7.4 million, around GBP4.4 million, which will be satisfied by the issue of 75.9 million shares. Bioasis is a multi-asset rare and orphan disease biopharmaceutical company. The deal was first announced last week. Midatech also plans an equity fundraising of USD10 million. The firm on Monday says that, having conferred with shareholders, it is now no longer seeking cancellation of its AIM listing.

----------

LBG Media PLC, down 17% at 80p, 12-month range 48.44p-213p. The Ladbible-owner said it expects annual revenue of GBP63 million in 2022, and adjusted earnings before interest, tax, depreciation, and amortisation of GBP16 million. In 2021, LBG posted revenue of GBP54.5 million and adjusted Ebitda of GBP16.8 million. "Given the momentum seen in [the second half], and cost reduction exercise completed in November 2022, management is confident about the outlook for continued growth in 2023," LBG said.

----------

AIM - LOSERS

----------

Angus Energy, down 21% at 1.47p, 12-month range 0.56p-2.95p. The energy company closes a GBP7.1 million equity fundraise, at a placing price of 1.65p. The price is an 11% discount to the closing price of 1.86p on Friday. The proceeds will be used to accelerate its drilling programme to expand production, evaluate acquisition opportunities, fund operational activities, as well as to settle of a liability recently arising from its hedging arrangements.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
24 Mar 2023 18:17

IN BRIEF: Midatech Pharma delisting and name change approved

Midatech Pharma PLC - Cardiff-based R&D biotechnology company focused on improving the bio-delivery and bio-distribution of medicines - Says resolutio...

17 Mar 2023 15:42

UK shareholder meetings calendar - next 7 days

15 Feb 2023 10:35

Midatech Pharma shares up as closed USD6.0 million private placement

(Alliance News) - Midatech Pharma PLC on Wednesday said it has raised USD6.0 million through a private placement of 10.3 million shares at USD0.58 eac...

9 Feb 2023 20:25

IN BRIEF: Midatech Pharma raises USD6.0 million for clinical asset

Midatech Pharma PLC - Cardiff-based R&D biotechnology company focused on improving the bio-delivery and bio-distribution of medicines - Raises gross p...

3 Feb 2023 11:42

Midatech's Nasdaq price falls below minimum of USD1.00 per share

(Alliance News) - Midatech Pharma PLC on Friday said it received notice that its share price has fallen short of the minimum needed according to Nasda...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.